3.3144
Protara Therapeutics Inc (TARA) 最新ニュース
Protara Therapeutics Inc. recovery potential after sell off2025 Market Overview & Growth Focused Investment Plans - Newser
What’s the recovery path for long term holders of Protara Therapeutics Inc.Weekly Trade Summary & Growth Oriented Trading Recommendations - Newser
Strategies to average down on Protara Therapeutics Inc.Analyst Upgrade & Free High Accuracy Swing Entry Alerts - Newser
Published on: 2025-08-13 04:45:31 - Newser
Tick level data insight on Protara Therapeutics Inc. volatility2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Using RSI to spot recovery in Protara Therapeutics Inc.Market Performance Summary & Consistent Profit Trading Strategies - Newser
Understanding Protara Therapeutics Inc.’s price movementBuy Entry Confirmation Based on Technical Analysis - Newser
Protara Therapeutics Inc. stock volume spike explainedFree AI-Powered Trade Planning with Indicators - Newser
Applying big data sentiment scoring on Protara Therapeutics Inc. [2025 Momentum Check]High Conviction Investment Ideas - Newser
News impact scoring models applied to Protara Therapeutics Inc. [Market Risk Analysis]Capital Protection Trade Alerts - Newser
Protara Therapeutics Reports Q2 2025 Financial Results - MSN
Backtesting results for Protara Therapeutics Inc. trading strategiesWeekly Return Plan for Conservative Traders - Newser
Published on: 2025-08-12 02:18:08 - Newser
Smart tools for monitoring Protara Therapeutics Inc.’s price actionFree Sector Based Breakout Stock Forecast - Newser
Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Is Protara Therapeutics Inc. in a bullish channelHigh Growth With Low Risk - mustnews.co.kr
Using data filters to optimize entry into Protara Therapeutics Inc.Growth Projection Summary for Long-Term Investors - Newser
Applying big data sentiment scoring on Protara Therapeutics Inc.Free Growth Focused Entry Plan Suggestions - Newser
Protara Therapeutics: Q2 Earnings Snapshot - San Antonio Express-News
Protara Therapeutics reports Q2 EPS (35c), consensus (38c) - TipRanks
Protara’s Losses Grew But Wall Street’s Still On Board - Finimize
Protara Beats Q2 Loss Estimates - The Motley Fool
Protara Therapeutics Q2 2025 Financial Results and Business Update - TradingView
Protara Therapeutics' Q2 net loss widens - MarketScreener
Protara Therapeutics, Inc. SEC 10-Q Report - TradingView
Protara (TARA) Announces Q2 2025 Results; Press Release Furnished | TARA SEC FilingForm 8-K - Stock Titan
Protara Therapeutics Reveals Strong $146M Cash Position, Multiple Clinical Milestones Coming in Next 6 Months - Stock Titan
Published on: 2025-08-10 02:01:28 - Newser
How Protara Therapeutics Inc. stock performs during market volatilityFree Pattern Alert With ROI Driven Strategy - Newser
Does Protara Therapeutics Inc. fit your quant trading modelFree Entry Alert With Low Drawdown Strategy - Newser
News impact scoring models applied to Protara Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser
Combining price and volume data for Protara Therapeutics Inc.Neural Network Based Equity Prediction System - Newser
What earnings revisions data tells us about Protara Therapeutics Inc.Free Trade Setups With AI Powered Filters - Newser
How to build a custom watchlist for Protara Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attentionSmart Entry Signals for Active Traders - Newser
What analysts say about Protara Therapeutics Inc. stockCapitalize on momentum stocks before they peak - Jammu Links News
When is Protara Therapeutics Inc. stock expected to show significant growthTransform your portfolio with high-yield stocks - Jammu Links News
How does Protara Therapeutics Inc. compare to its industry peersOutstanding trading profits - Jammu Links News
Should I hold or sell Protara Therapeutics Inc. stock in 2025Capitalize on market momentum for big wins - Jammu Links News
What catalysts could drive Protara Therapeutics Inc. stock higher in 2025Free Consultation - Jammu Links News
What are Protara Therapeutics Inc. company’s key revenue driversMaximize portfolio growth with expert advice - Jammu Links News
What are analysts’ price targets for Protara Therapeutics Inc. in the next 12 monthsPhenomenal returns - Jammu Links News
What is Protara Therapeutics Inc. company’s growth strategyGet real-time alerts on top stocks - Jammu Links News
大文字化:
|
ボリューム (24 時間):